{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-date=2020-09-17&tablingMemberConstituency=St+Albans", "definition" : "http://eldaddp.azurewebsites.net/meta/answeredquestions.text?min-date=2020-09-17&tablingMemberConstituency=St+Albans", "extendedMetadataVersion" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-date=2020-09-17&tablingMemberConstituency=St+Albans&_metadata=all", "first" : "http://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&min-date=2020-09-17&tablingMemberConstituency=St+Albans", "hasPart" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-date=2020-09-17&tablingMemberConstituency=St+Albans", "isPartOf" : "http://eldaddp.azurewebsites.net/answeredquestions.text?min-date=2020-09-17&tablingMemberConstituency=St+Albans", "items" : [{"_about" : "http://data.parliament.uk/resources/1722525", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1722525/answer", "answerText" : {"_value" : "
Integrated care boards (ICBs) are responsible for arranging access to the National Institute for Health and Care Excellence\u2019s (NICE) recommended treatments, therefore it is not driven by the Department. It is up to ICBs to determine the best model of access for their eligible population.<\/p>
Antiviral treatments for COVID-19 are now routinely available for National Health Service patients at highest risk of serious illness from COVID-19, in line with the approach to the rollout set out in the NICE\u2019s guidance published last year.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1506", "label" : {"_value" : "Biography information for Andrew Gwynne"} } , "answeringMemberConstituency" : {"_value" : "Gorton and Denton"} , "answeringMemberPrinted" : {"_value" : "Andrew Gwynne"} , "dateOfAnswer" : {"_value" : "2024-07-25", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-07-25T16:19:38.507Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-07-22", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Coronavirus: Medical Treatments"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, if he will take steps to reinstate the Covid Medicines Delivery Unit to provide access to antiviral drugs for people with covid-19 infections who are clinically vulnerable.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4769", "label" : {"_value" : "Biography information for Daisy Cooper"} } , "tablingMemberConstituency" : {"_value" : "St Albans"} , "tablingMemberPrinted" : [{"_value" : "Daisy Cooper"} ], "uin" : "1036"} , {"_about" : "http://data.parliament.uk/resources/1722074", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1722074/answer", "answerText" : {"_value" : "
No assessment has been made of the potential merits of including a dedicated section on congenital disorders of glycosylation in the UK Rare Diseases Framework. The framework was published in 2021, and provides a national vision for how to improve the lives of those living with rare diseases by addressing shared challenges, and does not focus on specific rare conditions.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1506", "label" : {"_value" : "Biography information for Andrew Gwynne"} } , "answeringMemberConstituency" : {"_value" : "Gorton and Denton"} , "answeringMemberPrinted" : {"_value" : "Andrew Gwynne"} , "dateOfAnswer" : {"_value" : "2024-07-25", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-07-25T16:24:34.573Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-07-18", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Congenital Disorder of Glycosylation"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of including a dedicated Congenital Disorders of Glycosylation section in the UK Strategy for Rare Diseases.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4769", "label" : {"_value" : "Biography information for Daisy Cooper"} } , "tablingMemberConstituency" : {"_value" : "St Albans"} , "tablingMemberPrinted" : [{"_value" : "Daisy Cooper"} ], "uin" : "679"} , {"_about" : "http://data.parliament.uk/resources/1722075", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1722075/answer", "answerText" : {"_value" : "
No assessment has been made of the potential merits of establishing a national patient register for congenital disorders of glycosylation. There are no plans in England for a specific registry for this condition. Metabolic patients are included in the National Disease Registration Service, which is now part of NHS England.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/1506", "label" : {"_value" : "Biography information for Andrew Gwynne"} } , "answeringMemberConstituency" : {"_value" : "Gorton and Denton"} , "answeringMemberPrinted" : {"_value" : "Andrew Gwynne"} , "dateOfAnswer" : {"_value" : "2024-07-25", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-07-25T16:26:04.393Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-07-18", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Congenital Disorder of Glycosylation"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of establishing a national patient register for Congenital Disorders of Glycosylation.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4769", "label" : {"_value" : "Biography information for Daisy Cooper"} } , "tablingMemberConstituency" : {"_value" : "St Albans"} , "tablingMemberPrinted" : [{"_value" : "Daisy Cooper"} ], "uin" : "680"} , {"_about" : "http://data.parliament.uk/resources/1721667", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1721667/answer", "answerText" : {"_value" : "
Integrated care boards (ICBs) are responsible for the provision and commissioning of local wheelchairs services. It is therefore the responsibility of ICBs to review and assess the quality of the provision of their commissioned National Health Service wheelchair services.<\/p>
As such, we do not currently have any plans to assess the adequacy of the provision of NHS wheelchair services provided by AJM Healthcare. NHS England is taking steps to support ICBs to make improvements and commission effective, efficient, and personalised wheelchair services.<\/p>
Data on waiting times for wheelchairs provided by AJM Healthcare is not held centrally. NHS England collects quarterly data from the ICBs through the National Wheelchair Data Collection, which is available through the following link:<\/p>